Concepedia

Ding-Zhou Weng

DW

Statistics

Publications

3

Citations

56

H-Index

3

Active since

2022

Affiliations

State Administration of Traditional Chinese Medicine of the People's Republic of China(Current)

Peking University

Ding-Zhou Weng is an author at State Administration of Traditional Chinese Medicine of the People's Republic of China specializing in smad signaling pathway, heart failure pharmacology, and cardiac pharmacotherapy.

Publications per year

2022–2025

3

Publications

3

Norwogonin attenuates LPS-induced acute lung injury through inhibiting Src/AKT1/NF-κB signaling pathway

Tianjiao Cao, Ying Zhang, Ding-Zhou Weng et al. · Phytomedicine · 2025 · 24 citations

, , +12

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway

Gulinigaer Anwaier, Tingting Xie, Chun‐Shui Pan et al. · Frontiers in Pharmacology · 2022 · 22 citations · Full text

, , +13

Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats

Hui‐Yu Chen, Jian Liu, Ding-Zhou Weng et al. · Frontiers in Pharmacology · 2022 · 10 citations · Full text

, , +16

1–3 of 3